Perrigo (PRGO) Tax Provisions (2012 - 2026)
Perrigo's (PRGO) quarterly Tax Provisions came in at -$18.7 million in Q1 2026, down 328.05% year-on-year from $8.2 million in Q1 2025, and down 122.56% on a QoQ basis from $82.9 million in Q4 2025.
Perrigo (PRGO) Tax Provisions (2012 - 2026) Analysis & Trends
Perrigo (PRGO) has 15 years of Tax Provisions data on file, last reported at -$18.7 million in Q1 2026.
- On a quarterly basis, Tax Provisions fell 328.05% year-over-year to -$18.7 million in Q1 2026; TTM through Mar 2026 was $77.6 million, a 59.33% decrease from a year earlier, with the FY2025 full-year figure at $104.4 million, up 30.5% from the prior year.
- Tax Provisions for Q1 2026 stood at -$18.7 million, down from $82.9 million in the prior quarter.
- Over the last five years, Tax Provisions for PRGO reached as high as $111.5 million in Q4 2024 and fell as low as -$102.7 million in Q1 2024.
- Historically, Tax Provisions has averaged $9.0 million across 5 years, with a median of $5.4 million in 2023.
- On a YoY basis, Tax Provisions climbed as much as 936.84% in 2024 and fell as far as 2001.85% in 2024.
- Year by year, Tax Provisions stood at -$1.6 million in 2022, then slumped by 1562.5% to -$26.6 million in 2023, then jumped by 519.17% to $111.5 million in 2024, then fell by 25.65% to $82.9 million in 2025, then tumbled by 122.56% to -$18.7 million in 2026.
- Per Business Quant data, the three most recent Tax Provisions figures were -$18.7 million in Q1 2026, $82.9 million in Q4 2025, and $9.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 67.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 157.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 676.90 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 43.40 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -423.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 48.90 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 30.00 Mn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | -18.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | -18.70 Mn |
| Dec 31, 2025 | 82.90 Mn |
| Sep 27, 2025 | 9.70 Mn |
| Jun 28, 2025 | 3.70 Mn |
| Mar 29, 2025 | 8.20 Mn |
| Dec 31, 2024 | 111.50 Mn |
| Sep 28, 2024 | 39.40 Mn |
| Jun 29, 2024 | 31.70 Mn |
| Mar 30, 2024 | -102.70 Mn |
| Dec 31, 2023 | -26.60 Mn |
| Sep 30, 2023 | 3.80 Mn |
| Jul 1, 2023 | 13.60 Mn |
| Apr 1, 2023 | 5.40 Mn |
| Dec 31, 2022 | -1.60 Mn |
| Oct 1, 2022 | 48.60 Mn |
| Jul 2, 2022 | -43.40 Mn |
| Apr 2, 2022 | -11.70 Mn |
| Dec 31, 2021 | -22.20 Mn |
| Oct 2, 2021 | 442.80 Mn |
| Jul 3, 2021 | -45.20 Mn |